Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

141 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration-resistant Prostate Cancer trial results

Completed

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02711956

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute Farmington Hills, Michigan, United States
View Trial Details
Completed

Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

NCT02111577

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Compassionate Care Research Group, Inc. Corona, California, United States
View all 177 locations
View Trial Details
Completed

Sequencing Abiraterone and Enzalutamide in mCRPC

NCT02125357

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • BC Cancer Agency - Abbotsford Abbotsford British Columbia, British Columbia, Canada
  • BC Cancer Agency - Southern Interior Kelowna, British Columbia, Canada
  • BC Cancer Agency - Centre for the North Prince George, British Columbia, Canada
  • BC Cancer Agency - Fraser Valley Surrey, British Columbia, Canada
View Trial Details
Completed

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

NCT02047253

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Birmingham VA Medical Center Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cancer Life Center, Navicent Health Macon, Georgia, United States
  • University of Tulane New Orleans, Louisiana, United States
View Trial Details
Completed

A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02705469

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute Farmington Hills, Michigan, United States
View Trial Details

Related conditions